Join
Live feed
·
PRReleasevia Quantisnow
ABIOMED Inc. logo
Johnson & Johnson logo

Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over Year

ByQuantisnow·Wall Street's wire, on your screen.
ABMD· ABIOMED Inc.JNJ· Johnson & Johnson
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABMD (ABIOMED Inc.), JNJ (Johnson & Johnson) and more on Quantisnow.